increased cardiac muscle contractility_Pln<tm1Egk>/Pln<tm1Egk>

http://metadb.riken.jp/0005599I129S2SvPasCF1Plntm1EgkPlntm1EgkPlntm1Egk

increased cardiac muscle contractility_Pln<tm1Egk>/Pln<tm1Egk>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• phospholamban
  http://metadb.riken.jp/db/mgi_rdf/MGI:97622

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Pln<tm1Egk>/Pln<tm1Egk>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Pln<tm1Egk>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S2/SvPas * CF1

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased cardiac muscle contractility
  http://purl.obolibrary.org/obo/MP_0005599

文献

http://purl.org/net/cito/citesAsAuthority

• W. Luo, et.al., Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation., Circulation research, 1994, 75
  http://rdf.ncbi.nlm.nih.gov/pubmed/8062415
• W F. Bluhm, et.al., Phospholamban: a major determinant of the cardiac force-frequency relationship., American journal of physiology. Heart and circulatory physiology, 2000, 278
  http://rdf.ncbi.nlm.nih.gov/pubmed/10644605